VIP-Producing Neuroendocrine Tumor — Trials

VIP-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04915144	177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs	withdrawn	Phase 2	0	British Columbia Cancer AgencyOTHER	1	Feb 21, 2023	clinicaltrials
NCT01229943	Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery	completed	Phase 2	150	National Cancer Institute (NCI)NIH	2	Aug 4, 2022	clinicaltrials
NCT00131911	Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors	completed	Phase 2	93	National Cancer Institute (NCI)NIH	1	Nov 17, 2014	clinicaltrials
NCT00075439

Data updated 22 days agoSource updated Feb 21, 2023source: clinicaltrials